Tag: Nirmatrelvir

According to initial clinical trials, Paxlovid reduced the risk of hospitalization or death by nearly 90% in unvaccinated, high-risk individuals with mild-to-moderate COVID-19. Given its demonstrated benefits, the question for many remains: **Is Paxlovid worth it?**

According to the Centers for Disease Control and Prevention (CDC), the overuse of antibiotics is a significant driver of antibiotic resistance. This fact is critical to understand when considering medications for infections like COVID-19, leading many to ask: **Is Paxlovid an antibiotic?** The answer is definitively no; Paxlovid is an antiviral medication specifically designed to fight the virus that causes COVID-19.